Preventive/remedy for cancer

Details for Australian Patent Application No. 2008264469 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Ohta, Yoshikazu; Hayashi, Akira

Agent Griffith Hack

Pub. Number AU-A-2008264469

PCT Pub. Number WO2008/156153

Priority 2007-161769 19.06.07 JP

Filing date 19 June 2008

Wipo publication date 24 December 2008

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

28 January 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 12 Jan 2010

28 January 2010 PCT application entered the National Phase

  PCT publication WO2008/156153 Priority application(s): WO2008/156153

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008264476-Composition for transdermal or transmucosal administration

2008264462-Reactor Employing High-Temperature Air Combustion Technology